Bioscience Valuation

Case Studies

Bioscience Valuation is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters,.


A leading Southern-European company was searching for in-licensing opportunities. Bioscience Valuation (BSV) screened the worldwide pharmaceutical markets in a comprehensive and systematic way.


Bioscience Valuation identified promising drugs that were EMA-approved and ready to get marketed; BSV drafted the term sheet and supported the negotiations. Bioscience Valuation’s client licensed the drug that is now distributed in the local market.